Analyst Research

Report Title Price
Provider : Stock Traders Daily
Provider : Reuters Investment Profile
Provider : Pechala's Reports
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Akebia Therapeutics Inc files registration statement for proposed initial public offering

Tuesday, 18 Feb 2014 10:00am EST 

Akebia Therapeutics Inc:Says the filing of a Registration Statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of shares of its common stock.Says all of the shares to be sold in the proposed offering will be offered by Akebia Therapeutics.Says it has applied for a listing of its common stock on The NASDAQ Stock Market under the symbol "AKBA".Says the number of shares to be offered and the price range for the offering have not yet been determined.Says Morgan Stanley, Credit Suisse and UBS Investment Bank are acting as joint book-running managers and Nomura is acting as a co-manager for the offering.